We are live on ! Find out more
HLVX

HilleVax
HLVX

Delisted

HLVX was delisted on the 16th of September, 2025.

Back to rankings

76 hedge funds and large institutions have $88.7M invested in HilleVax in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 15

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

21% more capital invested

Capital invested by funds: $73.5M → $88.7M (+$15.2M)

2.15% more ownership

Funds ownership: 83.85% → 86% (+2.2%)

4% less funds holding

Funds holding: 79 → 76 (-3)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

Holders
76
Holders Change
-3
Holders Change %
-3.8%
% of All Funds
1%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
10
Increased
32
Reduced
15
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$851K
2
Morgan Stanley
Morgan Stanley
New York
+$818K
3
JP Morgan Chase
JP Morgan Chase
New York
+$363K
4
Millennium Management
Millennium Management
New York
+$289K
5
SCM
Stonepine Capital Management
Oregon
+$249K

Top Sellers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
-$1.87M
2
TC
Trium Capital
United Kingdom
-$798K
3
SB
Samsara BioCapital
California
-$750K
4
AC
Almitas Capital
California
-$470K
5
CP
Catalys Pacific
Japan
-$416K
Name Holding Trade Value Shares
Change 		Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$22M – – –
TPC
2
Takeda Pharmaceutical Company
Japan
$13.9M – – –
TCM
3
Tang Capital Management
California
$10.2M – – –
LMC
4
Lightspeed Management Company
California
$4.85M +$4.4M +2,341,376 New
BlackRock
5
BlackRock
New York
$4.48M +$54.9K +29,234 +1%
Franklin Resources
6
Franklin Resources
California
$4.05M – – –
DM
7
Deerfield Management
New York
$3.9M – – –
CG
8
Carlyle Group
District of Columbia
$3.82M – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$3.32M +$61.6K +32,789 +2%
Balyasny Asset Management
10
Balyasny Asset Management
Illinois
$2.08M -$22.6K -12,057 -1%
SG
11
StepStone Group
California
$1.71M – – –
Goldman Sachs
12
Goldman Sachs
New York
$1.45M +$851K +453,018 +184%
Morgan Stanley
13
Morgan Stanley
New York
$1.42M +$818K +435,811 +173%
State Street
14
State Street
Massachusetts
$1.26M +$41.4K +22,074 +4%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.25M -$44.5K -23,717 -4%
Deutsche Bank
16
Deutsche Bank
Germany
$871K +$195K +104,001 +33%
Millennium Management
17
Millennium Management
New York
$852K +$289K +153,815 +60%
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$848K -$287K -152,652 -27%
SB
19
Samsara BioCapital
California
$827K -$750K -399,637 -50%
QUSVM
20
Qiming U.S. Ventures Management
Washington
$771K -$350K -186,308 -33%
Northern Trust
21
Northern Trust
Illinois
$517K +$13K +6,916 +3%
Bank of America
22
Bank of America
North Carolina
$480K +$148K +78,739 +51%
JP Morgan Chase
23
JP Morgan Chase
New York
$429K +$363K +193,124 +1,377%
Verition Fund Management
24
Verition Fund Management
Connecticut
$347K -$37.9K -20,200 -11%
SCM
25
Stonepine Capital Management
Oregon
$274K +$249K +132,347 New
1
2 3 4

HLVX Hedge Fund Activity: Q4 2024 in Review

76 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q4 2024, worth a combined $88.7M — up 21% from $73.5M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of HLVX and 10 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 32 added.

The largest buyer was Goldman Sachs, adding an estimated $851K. The largest seller was Braidwell, exiting entirely with an estimated $1.87M sold.

  • 76 institutional investors held HilleVax (HLVX) as of Q4 2024, down from 79 in Q3 2024.
  • Funds reported $88.7M of HilleVax stock for Q4 2024, up 21% quarter-over-quarter.
  • 10 funds opened new HilleVax positions in Q4 2024 and 13 closed out, a net change of -3 holders.
  • The largest HilleVax buyer in Q4 2024 was Goldman Sachs, an estimated $851K added.
  • The largest HilleVax seller in Q4 2024 was Braidwell, an estimated $1.87M sold.

Based on aggregated 13F filings for Q4 2024.